✦ LIBER ✦

Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease

✍ Scribed by Yusuf Yilmaz; Fatih Eren; Oya Yonal; Ramazan Kurt; Bilge Aktas; Cigdem Ataizi Celikel; Osman Ozdogan; Nese Imeryuz; Cem Kalayci; Erol Avsar

Book ID: 108714006
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 97 KB
Volume: 40
Category: Article
ISSN: 0014-2972
DOI: 10.1111/j.1365-2362.2010.02338.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adipocytokine levels in nonalcoholic fat

Adipocytokine levels in nonalcoholic fatty liver disease

✍ Teoman Dogru; Cemal Nuri Ercin; Serkan Tapan; Murat Kantarcioglu; Muammer Kara; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

Li et al. have analyzed golgi phosphoprotein 2 (GOLPH2) serum levels in a cohort of patients with liver cirrhosis, healthy controls, and patients with hepatocellular carcinoma (HCC). They found elevated serum levels of GOLPH2 (sGOLPH2) in early HCC cases. From their findings, the authors conclude th

Increased fructose consumption is associ

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

✍ Manal F. Abdelmalek; Ayako Suzuki; Cynthia Guy; Aynur Unalp-Arida; Ryan Colvin; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

The rising incidence of obesity and diabetes coincides with a marked increase in fructose consumption. Fructose consumption is higher in individuals with nonalcoholic fatty liver disease (NAFLD) than in age-matched and body mass index (BMI)-matched controls. Because fructose elicits metabolic pertur

Serum M30 levels: A potential biomarker

Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels

✍ Yusuf Yilmaz; Engin Ulukaya; Enver Dolar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

We congratulate Fracanzani and colleagues 1 on their insightful article identifying factors associated with severe liver disease in patients with nonalcoholic fatty liver disease (NAFLD) and normal aminotransferase levels. First, the authors have convincingly demonstrated that normal alanine aminotr

Uric acid levels and liver fibrosis in n

Uric acid levels and liver fibrosis in nonalcoholic fatty liver disease

✍ Elisabetta Bugianesi; Giulio Marchesini 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

We read with interest the articles on hepatic venous pressure gradient (HVPG) measurements. [1][2][3] We fully agree on the need to standardize HVPG measurements to get reliable, reproducible, and useful data. 1 We also agree that before recommending such measurements in clinical practice, it is nec

Increased serum levels of hyaluronate in

Increased serum levels of hyaluronate in liver disease

✍ Anna Engström-Laurent; Lars Lööf; Anders Nyberg; Torbjörn Schröder 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 483 KB

Recent animal studies show that endothelial cells in liver sinusoids are the main site for removal of sodium hyaluronate from the circulation. Few data with respect to hyaluronate metabolism are available in man. Serum hyaluronate levels were measured in 119 patients with liver disease by a sensitiv

Independent effects of physical activity

Independent effects of physical activity in patients with nonalcoholic fatty liver disease

✍ Alexis St. George; Adrian Bauman; Amanda Johnston; Geoffrey Farrell; Tien Chey; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB 👁 1 views

Nonalcoholic fatty liver disease, characterized by elevated liver enzymes, central obesity, and insulin resistance, is becoming increasingly prevalent. The effects of changes in physical activity on the metabolic profile of this group have not been reported. We assessed at 3 months the impact of a b